PRF Technologies (PRFX) Assets Average (2021 - 2025)
PRF Technologies' (PRFX) quarterly Assets Average came in at $11.6 million in Q4 2025, up 203.46% YoY from $3.8 million in Q4 2024, and up 47.64% on a QoQ basis from $7.8 million in Q2 2025.
PRF Technologies (PRFX) Assets Average (2021 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Assets Average data on file, last reported at $11.6 million in Q4 2025.
- Quarterly Assets Average rose 203.46% year-over-year to $11.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.6 million (up 203.46% YoY) and the FY2025 annual result came in at $8.3 million, up 236.24% from the prior year.
- Assets Average rose to $11.6 million in Q4 2025, from $7.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $20.6 million in Q2 2021 to a low of $2.9 million in Q1 2024.
- A 5-year average of $12.4 million and a median of $11.6 million in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average sank 74.69% — and 2025, when it surged 203.46%.
- Tracing PRFX's Assets Average over 5 years: stood at $19.7 million in 2021, then sank by 31.03% to $13.6 million in 2022, then slumped by 58.51% to $5.6 million in 2023, then slumped by 32.32% to $3.8 million in 2024, then surged by 203.46% to $11.6 million in 2025.
- The last three Assets Average figures came in at $11.6 million (Q4 2025), $7.8 million (Q2 2025), and $3.8 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 11.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.58 Mn |
| Jun 30, 2025 | 7.84 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Mar 31, 2024 | 2.88 Mn |
| Dec 31, 2023 | 5.64 Mn |
| Sep 30, 2023 | 9.60 Mn |
| Jun 30, 2023 | 9.37 Mn |
| Mar 31, 2023 | 11.37 Mn |
| Dec 31, 2022 | 13.59 Mn |
| Sep 30, 2022 | 15.42 Mn |
| Jun 30, 2022 | 16.85 Mn |
| Mar 31, 2022 | 18.39 Mn |
| Dec 31, 2021 | 19.71 Mn |
| Sep 30, 2021 | 20.09 Mn |
| Jun 30, 2021 | 20.60 Mn |
| Mar 31, 2021 | 19.58 Mn |